For instance, the percentage of GBM patients with detectable PD-L1 protein expression level varies from 61 to 88% according to different reports (32, 33), while the median percentage of PD-L1-expression cells in GBM is only 2.77% (32). This evidence concerns the gene CD274 and glioblastoma.